Shanghai Pioneer Holding (SEHK:1345) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

1345 Aktienübersicht

Die Shanghai Pioneer Holding Ltd, eine Investment-Holdinggesellschaft, vermarktet, fördert und verkauft pharmazeutische Produkte und medizinische Geräte hauptsächlich in der Volksrepublik China.

Über das Unternehmen

1345 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	1/6
Financial Health	5/6
Dividends	1/6

Belohnungen

Risikoanalyse

Hoher Anteil an nicht zahlungswirksame Erträge

Die Gewinnspannen (9.3%) sind niedriger als im Vorjahr (15.1%)

Shanghai Pioneer Holding Ltd Wettbewerber

IVD Medical Holding

SEHK:1931

HK$1.4b

Tycoon Group Holdings

SEHK:3390

HK$3.1b

Charmacy Pharmaceutical

SEHK:2289

HK$928.8m

Guanze Medical Information Industry (Holding)

SEHK:2427

HK$940.5m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Shanghai Pioneer Holding
Historical stock prices
Current Share Price	HK$1.92
52 Week High	HK$2.70
52 Week Low	HK$1.31
Beta	0.52
1 Month Change	1.59%
3 Month Change	42.22%
1 Year Change	-25.58%
3 Year Change	35.21%
5 Year Change	170.42%
Change since IPO	-50.00%

Aktuelle Nachrichten und Updates

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01

Recent updates

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29

Aktionärsrenditen

	1345	HK Healthcare	HK Markt
7D	-4.0%	3.1%	-0.1%
1Y	-25.6%	-20.0%	0.02%

Rendite im Vergleich zur Industrie: 1345 unter dem Niveau der Branche Hong Kong Healthcare, die im vergangenen Jahr eine Rendite von -20.6% erzielte.

Rendite vs. Markt: 1345 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von 2.7 erzielte.

Preisvolatilität

Is 1345's price volatile compared to industry and market?
1345 volatility
1345 Average Weekly Movement	7.7%
Healthcare Industry Average Movement	5.9%
Market Average Movement	7.3%
10% most volatile stocks in HK Market	15.7%
10% least volatile stocks in HK Market	3.7%

Stabiler Aktienkurs: 1345Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: 1345Die wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1996	345	Steven Yang	www.pioneer-pharma.com

Die Shanghai Pioneer Holding Ltd, eine Investment-Holding, vermarktet, fördert und verkauft pharmazeutische Produkte und medizinische Geräte hauptsächlich in der Volksrepublik China. Das Unternehmen bietet pharmazeutische Produkte für die Bereiche Ophthalmologie, Schmerztherapie, Herz-Kreislauf, Immunologie, Gynäkologie, Gastroenterologie und andere Therapiebereiche an. Außerdem vertreibt es Medizinprodukte, darunter Produkte für die Augenheilkunde, Orthopädie, Zahnheilkunde und Wundversorgung.

Shanghai Pioneer Holding Ltd's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Shanghai Pioneer Holding im Vergleich zum Marktanteil des Unternehmens?
1345 grundlegende Statistiken
Marktanteil	HK$2.25b
Gewinn(TTM)	HK$156.90m
Umsatz(TTM)	HK$1.69b

14.4x

Kurs-Gewinn-Verhältnis

1.3x

Kurs-Umsatz-Verhältnis

Ist 1345 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
1345 Gewinn- und Verlustrechnung (TTM)
Einnahmen	CN¥1.57b
Kosten der Einnahmen	CN¥898.43m
Bruttogewinn	CN¥668.24m
Sonstige Ausgaben	CN¥522.52m
Umsatz	CN¥145.72m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.12
Bruttomarge	42.65%
Nettogewinnspanne	9.30%
Schulden/Eigenkapital-Verhältnis	7.9%

Wie hat sich 1345 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

2.5%

Aktuelle Dividendenrendite

36%

Ausschüttungsquote

1345 Aktienübersicht

Belohnungen

Risikoanalyse

Shanghai Pioneer Holding Ltd Wettbewerber

SEHK:1931

HK$1.4b

SEHK:3390

HK$3.1b

SEHK:2289

HK$928.8m

SEHK:2427

HK$940.5m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Upcoming dividend of HK$0.024 per share

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Investor sentiment improves as stock rises 21%

Recent updates

Upcoming dividend of HK$0.024 per share

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Investor sentiment improves as stock rises 21%

Final dividend of HK$0.024 announced

Shanghai Pioneer Holding Ltd, Annual General Meeting, May 24, 2024

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding Ltd to Report Fiscal Year 2023 Results on Mar 25, 2024

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Now 23% overvalued

New minor risk - Share price stability

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Less than half of directors are independent

Shanghai Pioneer Holding Ltd Announces Board Changes

New major risk - Earnings quality

Upcoming dividend of HK$0.024 per share at 3.0% yield

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

First half 2023 earnings released: EPS: CN¥0.065 (vs CN¥0.10 in 1H 2022)

Shanghai Pioneer Holding Ltd Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on October 20, 2023

Shanghai Pioneer Holding Ltd to Report First Half, 2023 Results on Aug 29, 2023

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Investor sentiment deteriorates as stock falls 15%

Upcoming dividend of HK$0.048 per share at 2.4% yield

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Investor sentiment improves as stock rises 23%

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings released

Shanghai Pioneer Holding Ltd Provides Earnings Guidance for the Year Ended 31 December 2022

Shanghai Pioneer Holding Ltd to Report Fiscal Year 2022 Results on Mar 27, 2023

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Less than half of directors are independent

Upcoming dividend of HK$0.018 per share

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings Limited Announces Management Changes

Investor sentiment improved over the past week

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

First half 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.057 in 1H 2021)

China Pioneer Pharma Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 20 October 2022

China Pioneer Pharma Holdings Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of HK$0.064 per share

Less than half of directors are independent

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings Limited, Annual General Meeting, May 18, 2022

Full year 2021 earnings released: EPS: CN¥0.12 (vs CN¥0.043 in FY 2020)

China Pioneer Pharma Holdings Limited Announces Dividend for the Year Ended 31 December 2021, Payable on 10 June 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Executive Chairman recently sold HK$17m worth of stock

Investor sentiment improved over the past week

Erträge & Einnahmen